Botanical description
Evergreen barberry-family shrub worked from the root and stem bark. Mahonia aquifolium carries glossy holly-like leaves and dark blue berries, but the medicine sits in the yellow inner bark rich in berberine-type alkaloids. It is a bitter antimicrobial shrub, not a berry tonic.
Pharmacognosy intro
Mahonia aquifolium (Pursh) Nutt. (Berberidaceae), commonly known as Oregon grape, is an evergreen shrub native to the Pacific Northwest of North America. The root bark and stem bark are the primary medicinal parts, containing a rich alkaloid profile dominated by protoberberine isoquinoline alkaloids: berberine (the most pharmacologically significant, 1.5-6% of dried root bark), berbamine, oxyacanthine, jatrorrhizine, columbamine, oxyberberine, and corytuberine. Additionally, the bark contains bisbenzylisoquinoline alkaloids that contribute to the plant's anti-inflammatory profile. The bright yellow color of the inner bark is due entirely to berberine content.
Berberine, the primary active alkaloid, operates through a remarkably broad pharmacological mechanism. Its most thoroughly characterized action is activation of AMP-activated protein kinase (AMPK) through phosphorylation of Thr172 on both alpha1 and alpha2 subunits. AMPK activation cascades into enhanced glucose uptake, inhibition of intracellular glucose production, stimulation of glycolysis, and improved lipid and glucose metabolism — explaining berberine's demonstrated antidiabetic effects comparable to metformin in some clinical trials. At the cellular level, berberine intercalates into DNA, preventing DNA replication and cell proliferation, which underlies its antimicrobial and antiproliferative activity. It inhibits lipoxygenase and lipid peroxidation, reduces T-cell infiltration, suppresses COX-2 activity (reducing prostaglandin E2), and directly inhibits IL-8 production. The crude extract of Mahonia aquifolium stem bark additionally inhibits IL-1, TNF-alpha, and TNF-beta through its bisbenzylisoquinoline alkaloid fraction. In psoriasis, a 10% Mahonia aquifolium bark extract ointment demonstrated efficacy for moderately severe psoriasis vulgaris in clinical study (Wiesenauer & Ludtke, 1996), with the mechanism attributed to antiproliferative effects on keratinocytes and anti-inflammatory modulation of the immune response.
Mahonia aquifolium was a cornerstone of Native American medicine in the Pacific Northwest, used by the Coast Salish, Squaxin Island, and Quinault peoples for skin infections, digestive complaints, and as a general tonic. The Eclectics adopted it as a hepatic alterative and antiperiodic (antimalarial). It should be distinguished from the closely related Mahonia nervosa (dull Oregon grape) and Berberis vulgaris (European barberry), all of which share berberine as a principal constituent. Oregon grape root bark is listed in the United States Pharmacopeia National Formulary.
Why it works together
Oregon grape works through bitter alkaloid force. Berberine gives the plant its antimicrobial and gut-hepatic reputation, while the bark matrix keeps the herb from acting like an isolated supplement. It belongs where heat, irritation, and sluggish elimination are traveling together.
Editorial orientation
The Bitter Bark Corrector
Oregon grape is usually reached for when skin, liver, and digestion are all showing a hotter, more congested edge. It belongs first to the berberine-bitter lane.